CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 77 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02821104
NCT02821104N/ACompleted
CompareCT.gov

Complement and Cardiovascular Risk in Adolescents

Ohio State University·observational·Posted Jul 1, 2016·Updated Jun 11, 2021

In Brief

An observational study for Cardiovascular Disease and Type 2 Diabetes. Completed, enrolled 77 participants across 1 site.

Detailed Summary

This study evaluates how genetic variations in complement, a part of the immune system, affect cardiovascular risk in adolescents.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Disease, Type 2 Diabetes
CountriesUnited States
CollaboratorsAmerican Heart Association

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJul 1, 2016
Enrollment StartJun 1, 2016
Primary CompletionJun 30, 2018
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 10.0 years ago